GlassScriptPhysician profile
Landon Combs
NPI 1376513721
$1,779.40
in general payments reported to CMS, 2019-2025
19 companies · $176 in 2025
The $176 reported for 2025 was more than what a typical Adolescent Medicine (Pediatrics) provider received nationally (typical 2025 total: $99.31).
See the full distribution for Adolescent Medicine (Pediatrics)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $366 · 2020: $138 · 2021: $111 · 2022: $534 · 2023: $167 · 2024: $287 · 2025: $176.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $630.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $630.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $498.26 | 2019-2025 | Bexsero, Pediarix, Shingrix |
| Novo Nordisk INC | $417.77 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $174.07 | 2019-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $163.21 | 2022-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $78.33 | 2021 | |
| Genentech USA, INC. | $76.46 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $75.16 | 2019-2025 | Gardasil 9, M-M-R II, Vaxneuvance |
| Ucb, INC. | $75.00 | 2022 | |
| Seqirus USA INC | $39.39 | 2024 | Flucelvax, Fluad |
| Takeda Pharmaceuticals U.S.A., INC. | $31.00 | 2019-2021 | |
| Shire North American Group INC | $24.65 | 2019 | |
| Sanofi-Aventis U.S. LLC | $22.65 | 2024 | |
| Biohaven Pharmaceutical Holding Company LTD. | $19.19 | 2022 | |
| Ironshore Pharmaceuticals INC. | $16.62 | 2019 | |
| Medtronic, INC. | $15.54 | 2024 | Intellis Adaptivestim |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $14.00 | 2020 | |
| Abbvie INC. | $13.83 | 2024 | |
| Sanofi Pasteur INC. | $12.81 | 2023 | |
| Adlon Therapeutics L.P. | $11.46 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Landon Combs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.